Xylogenics Overview

  • Founded
  • 2008
Founded
  • Status
  • Private
  • Employees
  • 7
Employees
  • Latest Deal Type
  • Conv. Debt
  • Latest Deal Amount
  • $525K
Latest Deal Amount

Xylogenics General Information

Description

Provider of a yeast genomics platform. The company is engaged in the the engineering of modified yeast microorganisms to synthesize commercial chemicals.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Primary Office
  • 351 West 10th Street
  • Indianapolis, IN 46202
  • United States
+1 (317) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Xylogenics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Convertible Debt 20-Dec-2010 $525K 00000 Completed Startup
To view Xylogenics’s complete valuation and funding history, request access »

Xylogenics Executive Team (5)

Name Title Board Seat Contact Info
Joshua Heyen Ph.D Chief Executive Officer, President & Co-Founder
Matt Kelker Ph.D Chief Scientific Officer
Cary Woods Co-Founder
To view Xylogenics’s complete executive team members history, request access »

Xylogenics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial